While we await dedicated cardiovascular outcomes trials for Retatrutide, I believe the constellation of metabolic improvements points strongly toward cardioprotection
The authors highlight three urgent priorities: Reframing GLP1 receptor agonists as essential medicines to reduce multimorbidity and premature mortality Addressing inequitable access and affordability, particularly in low and middleincome countries Strengthening healthsystem capacity, alongside prevention and behavioural support, to deliver safe and effective obesity care As the paper makes clear, prevention and treatment are codependent, stigma remains a major barrier, and lessons from HIV show what is possible when access, advocacy and systems change move together.
The semaglutide dosage chart below can help guide you through your weight loss management journey: Weeks 1-4: 0.25 mg, weekly injection dosage Weeks 4-8: 0.5 mg, weekly injection dosage Weeks 8-12: 1 mg, weekly injection dosage Weeks 13+: Up to 2.4 mg, weekly injection dosage While this is the average plan for many people, your individual path may be different
Some are injectable peptides